Moreover, SHP2 was recognized as an oncogenic PTP which is required for signal transduction in numerous kinase pathways implicated in tumor growth, survival and migration, such as RAS-MAPK-ERK, PI3K-AKT and JAK-STAT [52,53]. This evidence concerns the gene PTPN11 and neoplasm.